S'abonner

The Effectiveness of Ketamine Compared to Opioid Analgesics for management of acute pain in Children in The Emergency Department: systematic Review - 18/10/22

Doi : 10.1016/j.ajem.2022.08.004 
Elham Alanazi, MS
 Saudi Arabia Ministry of Health, Al-Jouf, Maternity and Child Hospital, Saudi Arabia 

Abstract

Aim

The first objective of this systematic review was to investigate the effectiveness of ketamine compared to opioid analgesics for pain management in children aged two months to 18 years who have acute pain in the emergency department. The second objective was to compare the adverse events and side effects associated with ketamine with those associated with opioids used for pain management.

Background

Ketamine is increasingly being used as an alternative to opioids in the management of acute pain in the emergency department. In turn, there is increasing research attention to prove the efficacy of ketamine as an analgesic in children presenting in the emergency department.

Design

The design was pertinent for gathering and appraisal of evidence presented in the available RCTs.

Methods

A systematic review, using the JBI systematic review was completed. A computerised search from five databases; CINAHL, EMBASE, EMCARE and PubMed, and Cochrane. The included studies were appraised by JBI critical appraisal tool for randomized controlled trials and the study results analysed.

Results

Four randomized control trial studies were included in this systematic review. All the included studies compared ketamine with opioids (morphine and fentanyl) for the management of severe pain in children. The studies were of high methodological quality based on JBI critical appraisal outcome. Meta-analysis was not possible because of the heterogeneity of the studies, especially in terms of different outcome measures, and the approaches (pain assessment tool) used to measure the pain outcomes. The review identified that that ketamine demonstrated non-inferior analgesia effect compared to opioid medication (morphine or fentanyl) as determined by various pain scores used in different studies. However, ketamine use was associated with increased frequency of occurrence of temporary adverse effects that do not require clinical attention.

Discussion

Ketamine is a suitable alternative for opioid analgesics for the management of acute and severe pain in children in ED. The evidence generated by this study is that ketamine is non-inferior to opioids (morphine and fentanyl) in controlling acute pain in children.

Conclusion

Based on the findings from the review, ketamine is a suitable alternative for opioid analgesics for the management of acute and severe pain in children in ED. The minor transient side effects associated with ketamine should not limit the use of ketamine. Future studies should investigate the appropriate dosage and route of administration of ketamine to be used while managing pain among children with acute and severe pain in the emergency department.

Implications for Nursing & Health Policy

In this systematic review, the Joanna Briggs Institute standards [14] have been followed. is advisable for the Emergency Department health professionals to determine the appropriate dose for ketamine based on the child's characteristics, such as weight, age, and disease condition.

Le texte complet de cet article est disponible en PDF.

Keywords : Children, Ketamine, Opioid, Pain, Paediatrics, Intramuscular, Intranasal, Intravenous, Morphine, Management, Analgesia


Plan


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 61

P. 143-151 - novembre 2022 Retour au numéro
Article précédent Article précédent
  • High risk and low prevalence diseases: Lemierre's syndrome
  • Brandon M. Carius, Alex Koyfman, Brit Long
| Article suivant Article suivant
  • Cardiac contusions in the acute care setting: Historical background, evaluation and management
  • Riccardo Scagliola, Sara Seitun, Manrico Balbi

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.